ADIPOQ and Insulin resistance: Longitudinal and cross-sectional studies have shown that adiponectin concentration negatively correlates with the development of insulin resistance and predict the progression of type 2 diabetes and are associated with a variety of human metabolic and cardiovascular disease states, including obesity, essential hypertension, and coronary artery diseases [23].